Company / Current Assets per Share
Annovis Bio, Inc. Current Assets per Share History
FY2020-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$1.25
FY2023
5-year range
$1.25 / $6.67
FY2020-FY2023
Trend
-71.9%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has declined for 3 consecutive years, from $28.73 in FY2020 to $1.25 in FY2023.
Based on SEC 10-K filings.
1.25 in FY2023 with a 3-year CAGR of -64.8%.
Declined from $6.67 to $1.25 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -64.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Annovis Bio, Inc.'s current assets per share has declined for 3 consecutive years.
- In FY2023, current assets per share decreased 71.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -9.28 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $1.25 | -71.9% |
| FY2022 | $4.45 | -33.4% |
| FY2021 | $6.67 | -76.8% |
| FY2020 | $28.73 | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026